Joshua Nathaniel Silverman, Director at Marker Therapeutics, holds 170.55K shares in Marker Therapeutics (Ticker: MRKR), holds 88.78K shares in MyMD Pharmaceuticals (Ticker: MYMD). Most recently, Joshua Nathaniel Silverman ― shares of Marker Therapeutics on ― for an estimated value of ―.